A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor (DSM421) with improved drug-like properties for treatment and prevention of malaria av Phillips, M, White, K, Kokkonda, S, Deng, X, White, J, El Mazouni, F, Marsh, K, Tomchick, D, Manjalanagara, K, Rudra, K, Wirjanata, G, Noviyanti, R, Price, R, Marfurt, J, Shackleford, D, Chiu, F, Campbell, M, Jimenez Diaz, M, Ferrer-Bazaga, S, Angulo-Barturen, I, Martínez-Martínez, M, Lafuente-Monasterio, M, Kaminsky, W, Silue, K, Zeeman, A, Kocken, C, Leroy, D, Blasco, B, Rossignol, E, Rueckle, T, Matthews, D, Burrows, J, Waterson, D, Palmer, M, Rathod, P, Charman, S

Quinolone-3-diarylethers: a new class of antimalarial drug. av Nilsen, A, LaCrue, A, White, K, Forquer, I, Cross, R, Marfurt, J, Mather, M, Delves, M, Shackleford, D, Saenz, F, Morrisey, J, Steuten, J, Mutka, T, Li, Y, Wirjanata, G, Ryan, E, Duffy, S, Kelly, J, Sebayang, B, Zeeman, A, Noviyanti, R, Sinden, R, Kocken, C, Price, R, Avery, V, Angulo-Barturen, I, Jiménez-Díaz, M, Ferrer, S, Herreros, E, Sanz, L, Gamo, F, Bathurst, I, Burrows, J, Siegl, P, Guy, R, Winter, R, Vaidya, AB, Charman, SA, Kyle, D, Manetsch, R, Riscoe, M

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance. av O'Neill, P, Amewu, R, Charman, S, Sabbani, S, Gnädig, N, Straimer, J, Fidock, D, Shore, E, Roberts, N, Wong, M, Hong, W, Pidathala, C, Riley, C, Murphy, B, Aljayyoussi, G, Gamo, F, Sanz, L, Rodrigues, J, Cortes, C, Herreros, E, Angulo-Barturén, I, Jiménez-Díaz, M, Bazaga, S, Martínez-Martínez, M, Campo, B, Sharma, R, Ryan, E, Shackleford, D, Campbell, S, Smith, D, Wirjanata, G, Noviyanti, R, Price, R, Marfurt, J, Palmer, M, Copple, I, Mercer, A, Ruecker, A, Delves, M, Sinden, R, Siegl, P, Davies, J, Rochford, R, Kocken, C, Zeeman, A, Nixon, G, Biagini, G, Ward, S